
    
      Patients with de novo lesions treated in different Institutions in Buenos Aires Argentina
      were randomized to treat with a stainless steel stent ("euca STS Flex") or a drug-eluting
      stent (" euca STS Flex DE") with a coating of a biodegradable polymer matrix of hemoparin and
      paclitaxel.
    
  